Quoin Pharmaceuticals Ltd. (QNRX)

SEC FORM 4CLUSTER · 4 INSIDERS

$279,965.60

Purchase of 57,370 shares across 4 reporting persons.

Transaction Code P · Reporting Persons 4

Culverwell Anthony JamesPurchase of 6,146 shares at $4.88 per share.$29,992.48
Lawlor Sally Bridget, Chief Financial OfficerPurchase of 10,244 shares at $4.88 per share.$49,990.72
Myers Michael, Chief Executive OfficerPurchase of 20,490 shares at $4.88 per share.$99,991.20
Carter Denise P., Chief Operating OfficerPurchase of 20,490 shares at $4.88 per share.$99,991.20

Surfaced by rule: 4 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001104659-26-104402 · filed 2026-09-01 · View filing →

Source: SEC Form 4 · 0001104659-26-104403 · filed 2026-09-01 · View filing →

Source: SEC Form 4 · 0001104659-26-104404 · filed 2026-09-01 · View filing →

Source: SEC Form 4 · 0001104659-26-104405 · filed 2026-09-01 · View filing →

SEC FORM 4

$161,462.80

Acquisition (code A) of 31,352 shares at $5.15 per share.

Reporting Person Culverwell Anthony James · Transaction Code A

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001104659-26-103374 · filed 2026-08-28 · View filing →

SEC FORM 4

$177,850.10

Acquisition (code A) of 34,534 shares at $5.15 per share.

Reporting Person LANGER DENNIS · Transaction Code A

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001104659-26-103376 · filed 2026-08-28 · View filing →